Anne Urfer-Buchwalder

Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA.

Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.

M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan.

Neuropore Therapies, Inc. provides biopharmaceutical services. It also offers alpha-synuclein (ASYN), amyloid beta, autophagy, and publications programs. The company was founded by Eliezer Masliah in 2008 and is headquartered in San Diego, CA.

Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada.

Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong.

Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation.

Schaller-Nikolich Stiftung gGmbH is a German company that engages in social work activities services. The private company is based in Heidelberg, Germany. The CEO of the company is Karoly Nikolich.

MapLight Therapeutics, Inc. engages in the development of novel therapeutics for brain disorders. The company is headquartered in San Francisco, CA.

NeuroTherapia, Inc. discovers and develops new therapies for diseases with an underlying component of neuroinflammation. The company was founded by Mohamed Naguib Attala and Joseph F. Foss in 2015 and is headquartered in Cleveland, OH.

Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Neurofluidics, Inc. develops neurological therapies. It also develops targeted and logical treatment approaches for patients suffering from neurological disorders. The company was founded in 2008 and is headquartered in Menlo Park, CA.

Chase Therapeutics Corp. operates as healthcare company. The company was founded in 2017 and is headquartered in Washington, DC.

Circuit Therapeutics, Inc. provides therapy and health care services. It specializes in optogenetics, gene therapy, neuromodulation and drug discovery services. The company was founded by Karl Deisseroth, Rob Malenka, Scott Delp, Thomas Sudhof and Karoly Nikolich and is headquartered in Menlo Park, CA.

Excelimmune, Inc. provides laboratory and biotechnology services. It is a biopharmaceutical company specializing in the development of recombinant polyclonal antibodies to create novel therapies for treating disease in humans. The firm’s next generation technology is applicable to the treatment of diseases and infections caused by common bacteria, disease-causing proteins and viral pathogens. The company was founded in 2006 by Quinton Y. Zondervan and Vincent W. Coljee and is headquartered in Lexington, MA.

Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA.